Conditional expression of exogenous Bcl‐XS triggers apoptosis in human melanoma cells in vitro and delays growth of melanoma xenografts

Publisher Website
Google Scholar
Abstract
The Bcl-2-related proteins Bcl-XL and Bcl-XS represent alternative splice products and exert opposite activities in the control of apoptosis, but their significance for melanoma is not yet clear. Applying the tetracycline-inducible expression system Tet-On, we found overexpression of Bcl-XS by itself sufficient to induce apoptosis in vitro in stably transfected human melanoma cell lines. Combination with proapoptotic agents such as etoposide, pamidronate, and ceramide resulted in additive proapoptotic effects, whereas Bcl-XL protected from apoptosis caused via CD95/Fas stimulation. In nude mice growth of melanoma xenotransplants derived from stably transfected cells was significantly reduced after induction of Bcl-XS by doxycycline. Our results indicate that Bcl-X proteins are of major importance for control of apoptosis in malignant melanoma